Computational Modeling of Antibody-Antigen Complexes: PLM-Based and MSA-Based Approaches

• URL: http://arxiv.org/abs/2605.28886v1
• Date: Wed, 27 May 2026 03:43:52 GMT
• Title: Computational Modeling of Antibody-Antigen Complexes: PLM-Based and MSA-Based Approaches
• Abstract summary: This thesis investigates why antibody-related tasks are harder and proposes improvements along two complementary directions.<n>First, we investigate protein language model (PLM)-based methods for antibody and antibody-antigen structure prediction.<n>Second, we develop two MSA-based interventions for antibody-antigen complex prediction.
• Score: 17.202242036098003
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Antibodies play a central role in the immune response by specifically recognizing and neutralizing antigens, and therapeutic antibodies have become major drugs for cancer and autoimmune diseases. However, their discovery still relies on extensive in vitro screening, and accurate computational modeling of antibody structures and antibody-antigen interactions can prioritize candidates, reduce experimental burden, and accelerate rational design. Despite recent advances in high-accuracy protein and complex prediction, a persistent performance gap remains for antibody-related tasks compared with general protein-protein interactions, limiting downstream design. This thesis investigates why antibody-related tasks are harder and proposes improvements along two complementary directions. First, we investigate protein language model (PLM)-based methods for antibody and antibody-antigen structure prediction. Using embeddings from multiple PLMs, our approach achieves the best CDR-H3 accuracy among compared PLM-based methods on antibody monomer prediction. Extending it to complex prediction does not generalize: without co-evolutionary signals between antibody and antigen, single-sequence PLM representations do not reliably identify binding interfaces. Second, we develop two MSA-based interventions for antibody-antigen complex prediction: MSA refinement, which combines CDR-focused filtering with depth recovery from a larger sequence database, and convergence-aware recycling, which selects a stable intermediate recycle state for final diffusion sampling. Together, these interventions provide consistent gains over the AlphaFold3 baseline on a held-out antibody-antigen test set. Because the methods modify MSA construction and recycling behavior rather than model parameters, they apply without retraining or weight access.

Related papers

• ABConformer: Physics-inspired Sliding Attention for Antibody-Antigen Interface Prediction [3.947298454012977]
  We present ABCONFORMER, a model based on the Conformer backbone that captures both local and global features of a biosequence.<n>ABCONFORMER can accurately predict paratopes and antigens given the antibody and sequence, and predict pan-epitopes on the antigen without antibody information.
  arXiv  Detail & Related papers  (2025-09-27T11:12:04Z)
• dyAb: Flow Matching for Flexible Antibody Design with AlphaFold-driven Pre-binding Antigen [52.809470467635194]
  Development of therapeutic antibodies heavily relies on accurate predictions of how antigens will interact with antibodies.<n>Existing computational methods in antibody design often overlook crucial conformational changes that antigens undergo during the binding process.<n>We introduce dyAb, a flexible framework that incorporates AlphaFold2-driven predictions to model pre-binding antigen structures.
  arXiv  Detail & Related papers  (2025-03-01T03:53:18Z)
• Leveraging Large Language Models to Predict Antibody Biological Activity Against Influenza A Hemagglutinin [0.15547733154162566]
  We develop an AI model for predicting the binding and receptor blocking activity of antibodies against influenza A hemagglutininin (HA) antigens.<n>Our models achieved an AUROC $geq$ 0.91 for predicting the activity of existing antibodies against seen HAs and an AUROC of 0.9 for unseen HAs.
  arXiv  Detail & Related papers  (2025-02-02T06:48:45Z)
• Relation-Aware Equivariant Graph Networks for Epitope-Unknown Antibody Design and Specificity Optimization [61.06622479173572]
  We propose a novel Relation-Aware Design (RAAD) framework, which models antigen-antibody interactions for co-designing sequences and structures of antigen-specific CDRs.<n> Furthermore, we propose a new evaluation metric to better measure antibody specificity and develop a contrasting specificity-enhancing constraint to optimize the specificity of antibodies.
  arXiv  Detail & Related papers  (2024-12-14T03:00:44Z)
• Antigen-Specific Antibody Design via Direct Energy-based Preference Optimization [51.28231365213679]
  We tackle antigen-specific antibody sequence-structure co-design as an optimization problem towards specific preferences. We propose direct energy-based preference optimization to guide the generation of antibodies with both rational structures and considerable binding affinities to given antigens.
  arXiv  Detail & Related papers  (2024-03-25T09:41:49Z)
• A Hierarchical Training Paradigm for Antibody Structure-sequence Co-design [54.30457372514873]
  We propose a hierarchical training paradigm (HTP) for the antibody sequence-structure co-design. HTP consists of four levels of training stages, each corresponding to a specific protein modality. Empirical experiments show that HTP sets the new state-of-the-art performance in the co-design problem.
  arXiv  Detail & Related papers  (2023-10-30T02:39:15Z)
• xTrimoABFold: De novo Antibody Structure Prediction without MSA [77.47606749555686]
  We develop a novel model named xTrimoABFold to predict antibody structure from antibody sequence. The model was trained end-to-end on the antibody structures in PDB by minimizing the ensemble loss of domain-specific focal loss on CDR and the frame-aligned point loss.
  arXiv  Detail & Related papers  (2022-11-30T09:26:08Z)
• Incorporating Pre-training Paradigm for Antibody Sequence-Structure Co-design [134.65287929316673]
  Deep learning-based computational antibody design has attracted popular attention since it automatically mines the antibody patterns from data that could be complementary to human experiences. The computational methods heavily rely on high-quality antibody structure data, which is quite limited. Fortunately, there exists a large amount of sequence data of antibodies that can help model the CDR and alleviate the reliance on structure data.
  arXiv  Detail & Related papers  (2022-10-26T15:31:36Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.